TCL Archive Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint May 31, 2013
TCL Archive Cooperative Group Chairman Objects “Personal” Comments, Other Deficiencies In Peer Review January 16, 1981
TCL Archive HHS Task Force Says NCI Drug Program Effective, Otters Suggestions; DeVita Responds March 26, 1982
TCL Archive As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data. October 22, 2004
TCL Archive Feds Set Guidelines For Pharma To Help Patients With Cost Of Drugs, While Steering Clear Of Anti-Kickback Law. April 28, 2006
